Article | October 16, 2018

Finding The Balance Between Cost And Innovation: Equipping A Flexible Facility With The Right Partner

By Justin Kadis

Finding The Balance Between Cost And Innovation: Equipping A Flexible Facility With The Right Partner

As the pharmaceutical industry has diversified, there has been a shift in the way facilities are structured. The industry has begun to lean toward wider adoption of multi-product or flexible facilities in an effort to maximize production and prove to customers that any request can be fulfilled by a singular company that is not bound to traditional methods of production.

Many pharmaceutical companies are looking to concentrate their outsourcing to one or a few contract firms that can handle the bulk of their production needs. If a contract developing and manufacturing organization (CDMO) is able to front-load the majority of their drug development and production, the pharmaceutical company sponsor eliminates major risks in the supply chain that can result from employing too many partners at all phases.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: